CDC Director Brenda Fitzgerald, MD, resigned Wednesday, one day after reports that she traded tobacco stocks while heading the agency.
CDC Director Brenda Fitzgerald, MD, resigned Wednesday, one day after reports that she traded tobacco stocks while heading the agency.
"This morning Secretary Azar accepted Dr. Brenda Fitzgerald’s resignation as Director of the Centers for Disease Control and Prevention," HHS said in a statement.
The statement said she "owns certain complex financial interests" that she could not sell "in a definitive time period."
The resignation leaves the CDC without a leader in the middle of a severe flu crisis that has gripped most of the nation.
Fitzegerald was appointed last July by President Trump and was previously Georgia’s public health commissioner.
The stock was one of about a dozen new investments that Fitzgerald made after she took over the agency’s top job, according to a report in Politico on Tuesday. Besides the tobacco stocks - an obvious conflict with the CDC's mission of promoting public health - she also purchased pharmaceutical , health insurance, and food company stocks.
But before it became know that she had purchased stocks after she began her CDC position, Fitzgerald was already under fire on Capitol Hill because the complicated investments were preventing her from appearing before Congress, Politico also reported earlier his month.
Her short tenure was marked by other controversy as well. In December, a CDC budget analyst told the media that 7 banned words had to be avoided in any budget requests. Fitzgerald denied that that any words were banned.
While in Georgia, Fitzgerald's agency accepted $1 million from Coca-Cola to fight childhood obesity in the state, which set off a debate over whether a soft-drink company could or should have a role in a a related public health issue. Fitzgerald's post about the effort is still visible on the Coca-Cola website.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More